Business Description
eFFECTOR Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US28202V2079
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.25 | |||||
Equity-to-Asset | 0.03 | |||||
Debt-to-Equity | 24.48 | |||||
Debt-to-EBITDA | -0.64 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 71.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 25.5 | |||||
9-Day RSI | 24.87 | |||||
14-Day RSI | 23.87 | |||||
6-1 Month Momentum % | -86.87 | |||||
12-1 Month Momentum % | -93.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.03 | |||||
Quick Ratio | 1.03 | |||||
Cash Ratio | 0.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -22.7 | |||||
Shareholder Yield % | -598713.34 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -148.44 | |||||
ROIC % | -146.54 | |||||
3-Year ROIIC % | -307.36 | |||||
ROC (Joel Greenblatt) % | -10343.79 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.01 | |||||
Price-to-Tangible-Book | 0.01 | |||||
EV-to-EBIT | 0.16 | |||||
EV-to-Forward-EBIT | -0.72 | |||||
EV-to-EBITDA | 0.16 | |||||
EV-to-Forward-EBITDA | -0.72 | |||||
EV-to-FCF | 0.18 | |||||
Earnings Yield (Greenblatt) % | 625 | |||||
FCF Yield % | -487916.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
eFFECTOR Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -12.091 | ||
Beta | 0 | ||
Volatility % | 86.42 | ||
14-Day RSI | 23.87 | ||
14-Day ATR (€) | 0.024269 | ||
20-Day SMA (€) | 1.08125 | ||
12-1 Month Momentum % | -93.75 | ||
52-Week Range (€) | 1.055 - 18.125 | ||
Shares Outstanding (Mil) | 4.7 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
eFFECTOR Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
eFFECTOR Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
eFFECTOR Therapeutics Inc Frequently Asked Questions
What is eFFECTOR Therapeutics Inc(FRA:LWK)'s stock price today?
When is next earnings date of eFFECTOR Therapeutics Inc(FRA:LWK)?
Does eFFECTOR Therapeutics Inc(FRA:LWK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |